Karl C. Podratz

Mayo Clinic

Papers

2

Total Citations

81

H-Index

2

About

Karl C. Podratz is a leading figure in gynecologic oncology, with research spanning the cytogenetics of ovarian cancer and the optimization of surgical outcomes in endometrial cancer. His seminal work, "Cytogenetic studies of epithelial ovarian carcinoma" (1993, 78 citations), provided foundational insights into the chromosomal abnormalities driving ovarian malignancies, advancing the understanding of tumor biology. Podratz also made critical contributions to postoperative care, as highlighted in his study on predictors and costs of surgical site infections (SSIs) in endometrial cancer patients (2013). This work underscored the substantial morbidity and mortality linked to SSIs, while advocating for the adoption of minimally invasive techniques—vaginal, laparoscopic, and robotic—to reduce complications and improve recovery. His research has directly influenced clinical practices, emphasizing the importance of infection prevention and cost-effective surgical strategies. With a career dedicated to bridging molecular genetics and surgical innovation, Podratz’s impact is evident in both the laboratory and the operating room, shaping modern approaches to gynecologic cancer care and patient safety.

Research Focus

Key Achievements

2
H-Index
2
Papers
81
Total Citations
41
Avg Citations/Paper
🏆 Most Cited Paper
Cytogenetic studies of epithelial ovarian carcinoma
78 citations · 1993
📈 Most Prolific Year: 1993 (1 Papers)
🤝 Key Collaborators: 16
🏛 Institutions: Mayo Clinic

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago